University of Southampton Pancreatic Cancer Screening Programmme (ClearNote)

Register now

The Pancreatic Cancer Screening programme is focused on the roll-out of a clinical trial to improve the detection of pancreatic cancer for people diagnosed with type 2 diabetes which is essential to increase the likelihood of successful treatment and survival.

In the UK, pancreatic cancer is the 10th most common cancer and the 5th most common cause of death by cancer (Cancer Research UK, n.d.).

The trial is jointly sponsored by University of Southampton and ...


As a practice, you can drive forward this screening study by registering today. Please click on the 'Register now' button above.

Placeholder Image

Why should I get my practice involved?

Register Now

As healthcare professionals, we have a shared goal to advance healthcare as we know it and make positive change happen for others.

This is a fully funded initiative at no cost to your practice and there is no noticeable increase on practice workload.

Registering your practice ensures you are part of a vital trial in detection of pancreatic cancer. Working with iPLATO, SMS messages will be sent to your practices eligible patients, providing them the opportunity to participate.

It's simple and easy to support:

Step 1: Register your practice.

Step 2: Have a 5-minute set-up call (if required).

Step 3: Provide list of eligible patients NHS numbers to our secure NHS mail inbox.

Step 4: We do the rest.

How will it work?

  • Eligible patients will be sent an SMS message providing them with information regarding the study and inviting them to complete a short online survey.
  • The patient will consent to take part in the trial and share their survey results. This will be shared for the duration for the programme with the relevant data processors.
  • Based on responses, a randomised selection of patients will be invited through SMS to book a screening appointment via iPLATO's online Web Booking system. They will be able to cancel and change appointments, and provided with automated appointment reminders to help prevent missed appointments. There will be administrative access for clinical staff so they can view booking details including date, time, and location.
  • iPLATO will send follow up SMS messages every 6 months inviting patients to complete a blood test.
  • iPLATO will provide regular progress updates and project reports.
  • This SMS Programme will be in addition to any existing programmes. 


Data Processing and Data Sharing Summary

  • The practice provides a list of eligible patients NHS numbers to our secure NHS mail inbox.
  • iPLATO will facilitate the ongoing extraction of client demographic data via the practice clinical system phonebook, for which the data will be minimised as far as possible.
  • All data is processed within the HSCN network.
  • Only patients who have consented to receive SMS will be contacted.
  • iPLATO Healthcare acts as a Data Processor for this service.
  • iPLATO will ensure data is transferred safely and is used in line with data sharing governance arrangements agreed with the University of Southampton.